Acute complications in children with sickle cell disease: Prevention and management

Area of Science:

• Pediatrics
• Hematology
• Genetics

Background:

• Sickle cell disease (SCD) is a chronic, multi-system inherited blood disorder.
• Red blood cell sickling causes hemolysis and vascular occlusion, leading to anemia and organ damage.
• Increasing newborn screening necessitates pediatric provider knowledge of SCD across Canada.

Purpose of the Study:

• To provide guidance on the prevention, advocacy, and rapid treatment of acute SCD complications.
• To update healthcare providers on newborn screening, immunizations, antibiotic prophylaxis, and hydroxyurea therapy.
• To illustrate care principles for common SCD acute complications through case vignettes.

Main Methods:

• Review of current literature and guidelines on SCD management.
• Development of recommendations for prevention and acute complication treatment.
• Inclusion of case vignettes for practical application of care principles.

Main Results:

• Guidance on newborn screening, immunizations, and antibiotic prophylaxis.
• Introduction to hydroxyurea for reducing childhood SCD morbidity and mortality.
• Detailed principles for managing vaso-occlusive episodes, acute chest syndrome, fever, splenic sequestration, aplastic crises, and stroke.

Conclusions:

• Pediatric health care providers need to be knowledgeable about SCD for comprehensive care.
• Early diagnosis and management of SCD complications are crucial.
• This statement provides essential principles for managing children with SCD, including transfusion therapy.